Your browser doesn't support javascript.
loading
Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer - Results from a prospective cohort study.
Marschner, Norbert; Arnold, Dirk; Engel, Erik; Hutzschenreuter, Ulrich; Rauh, Jacqueline; Freier, Werner; Hartmann, Holger; Frank, Melanie; Jänicke, Martina.
Affiliation
  • Marschner N; Praxis für Interdisziplinäre Onkologie und Hämatologie, Freiburg, Germany.
  • Arnold D; Klinik für Tumorbiologie, Freiburg, Germany.
  • Engel E; Hämatologisch - Onkologische Praxis Altona, Hamburg, Germany.
  • Hutzschenreuter U; Hämatologisch - Onkologische Gemeinschaftspraxis, Nordhorn, Germany.
  • Rauh J; Fachinternistische Gemeinschaftspraxis und Therapiezentrum, Witten, Germany.
  • Freier W; Onkologische Praxis, Hildesheim, Germany.
  • Hartmann H; Clinical Epidemiology and Health Economics, iOMEDICO, Freiburg, Germany.
  • Frank M; Statistics, iOMEDICO, Freiburg, Germany.
  • Jänicke M; Clinical Epidemiology and Health Economics, iOMEDICO, Freiburg, Germany.
Clin Epidemiol ; 7: 295-303, 2015.
Article in En | MEDLINE | ID: mdl-25945067
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Clin Epidemiol Year: 2015 Type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Clin Epidemiol Year: 2015 Type: Article Affiliation country: Germany